Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Abstract Background Recent studies have shown that immune-related adverse events (irAEs) caused by immune checkpoint inhibitors were associated with clinical benefit in patients with melanoma or lung cancer. In advanced gastric cancer (AGC) patients, there have been few reports about the correlation...

Full description

Bibliographic Details
Main Authors: Ken Masuda, Hirokazu Shoji, Kengo Nagashima, Shun Yamamoto, Masashi Ishikawa, Hiroshi Imazeki, Masahiko Aoki, Takahiro Miyamoto, Hidekazu Hirano, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Atsuo Takashima, Ken Kato, Narikazu Boku
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Cancer
Subjects:
Gastric cancer
Immune-related adverse events
Nivolumab
Programmed cell death-1
Online Access:http://link.springer.com/article/10.1186/s12885-019-6150-y

Internet

http://link.springer.com/article/10.1186/s12885-019-6150-y

Similar Items